Resultados de procura - José Garnacho‐Montero

Limitar resultados
  1. 1
    Approach to invasive pulmonary aspergillosis in critically ill patients

    Approach to invasive pulmonary aspergillosis in critically ill patients por Despoina Koulenti, José Garnacho‐Montero, Stijn Blot

    Publicado 2014
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Antibiotic de-escalation in the ICU

    Antibiotic de-escalation in the ICU por José Garnacho‐Montero, Ana Escoresca‐Ortega, Esperanza Fernández-Delgado

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Fungal infections in immunocompromised critically ill patients

    Fungal infections in immunocompromised critically ill patients por José Garnacho‐Montero, Irene Barrero-García, Cristina León-Moya

    Publicado 2024
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Severe community-acquired pneumonia: current management and future therapeutic alternatives

    Severe community-acquired pneumonia: current management and future therapeutic alternatives por José Garnacho‐Montero, Irene Barrero-García, Maria de Gracia Gómez-Prieto, Ignacio Martín‐Loeches

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality

    Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality por José Garnacho‐Montero, Antonio Gutiérrez‐Pizarraya, Ana Escoresca‐Ortega, Esperanza Fernández-Delgado, José María López-Sánchez

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis.

    Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis. por José Garnacho‐Montero, T. Aldabó-Pallás, Carmen Garnacho, Aurelio Cayuela, R. Jiménez, Sónia Barroso, Carlos Ortíz-Leyba

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Timing of antibiotic therapy in the ICU

    Timing of antibiotic therapy in the ICU por Marin H. Kollef, Andrew F. Shorr, Matteo Bassetti, Jean‐François Timsit, Scott T. Micek, Andrew P. Michelson, José Garnacho‐Montero

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease

    Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease por Rosario Amaya-Villar, José Garnacho‐Montero, J.L. García Garmendia, Juan Madrazo-Osuna, Carmen Garnacho, Rafael Luque, Carlos Ortíz-Leyba

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis: a prospective nation-wide study in Spain

    Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis: a prospective nation-wide study in Spain por David L. Suarez, Ricard Ferrer, Antonio Artigas, I. Azkárate, José Garnacho‐Montero, Gemma Gomà, Mitchell M. Levy, Juan Carlos Ruiz

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients

    Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients por Ricard Ferrer, Xavier Mateu, Emilio Maseda, Juan Carlos Yébenes, César Aldecoa, Candelaria de Haro, Juan Carlos Ruiz‐Rodríguez, José Garnacho‐Montero

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  11. 11
    Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome.

    Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. por José Garnacho‐Montero, Rosario Amaya-Villar, Carlos Ortíz-Leyba, Cristóbal León, Francisco Álvarez-Lerma, Juan Nolla‐Salas, José Ramón Iruretagoyena, Fernando Barroso-Barcenilla

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Risk Factors for<i>Acinetobacter baumannii</i>Nosocomial Bacteremia in Critically Ill Patients: A Cohort Study

    Risk Factors for<i>Acinetobacter baumannii</i>Nosocomial Bacteremia in Critically Ill Patients: A Cohort Study por J.L. García Garmendia, Carlos Ortíz-Leyba, José Garnacho‐Montero, F. J. Jiménez-Jiménez, C. Pérez-Paredes, A Barrero-Almodóvar, Miguel Gili‐Miner

    Publicado 2001
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings

    Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings por José Garnacho‐Montero, Carlos Ortíz-Leyba, Esteban Fernández-Hinojosa, T. Aldabó-Pallás, Aurelio Cayuela, Juan Antonio Márquez-Vácaro, A. García-Curiel, F. J. Jiménez-Jiménez

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia

    Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia por Jordi Rello, Alejandro Rodríguez, Antoni Torres, Jorge Roig, Jordi Solé‐Violán, José Garnacho‐Montero, M. V. de la Torre, Josep Maria Sirvent, María Bodí

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii

    The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acineto... por T. Amat, Antonio Gutiérrez‐Pizarraya, Isabel Machuca, Irene Gracia-Ahufinger, Elena Pérez‐Nadales, Á. Torre‐Giménez, José Garnacho‐Montero, José Miguel Cisneros, Julián Torre‐Cisneros

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study

    Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study por José Garnacho‐Montero, Carlos Ortíz-Leyba, Inmaculada Concepción Herrera-Melero, T. Aldabó-Pallás, Aurelio Cayuela, Juan Antonio Márquez-Vácaro, J. Carbajal-Guerrero, J.L. García Garmendia

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Risk Factors for Fluconazole-Resistant Candidemia

    Risk Factors for Fluconazole-Resistant Candidemia por José Garnacho‐Montero, Ana Díaz‐Martín, Emilio García-Cabrera, Maite Ruiz Pérez de Pipaón, C Hernandez-Caballero, Javier Aznar, José Miguel Cisneros, Carlos Ortíz-Leyba

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis

    Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis por José Garnacho‐Montero, María J Huici-Moreno, Antonio Gutiérrez‐Pizarraya, Isabel López, Juan Antonio Márquez-Vácaro, Hada C. Macher, Juan M. Guerrero, Antonio Puppo-Moreno

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    European intensive care physicians’ experience of infections due to antibiotic-resistant bacteria

    European intensive care physicians’ experience of infections due to antibiotic-resistant bacteria por Alain Lepape, Astrid Jean, Jan J. De Waele, Arnaud Friggeri, Anne Savey, Philippe Vanhems, Marie Paule Gustin, Dominique L Monnet, José Garnacho‐Montero, Anke Kohlenberg

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients

    Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients por José Garnacho‐Montero, Juan Madrazo-Osuna, J.L. García Garmendia, Carlos Ortíz-Leyba, F. J. Jiménez-Jiménez, A Barrero-Almodóvar, Carmen Garnacho, M. Moyano-Del-Estad

    Publicado 2001
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: